234 related articles for article (PubMed ID: 9564789)
21. Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells.
Chang JY; Chang CY; Kuo CC; Chen LT; Wein YS; Kuo YH
Mol Pharmacol; 2004 Jan; 65(1):77-84. PubMed ID: 14722239
[TBL] [Abstract][Full Text] [Related]
22. Effects of the antimitotic natural product dolastatin 10, and related peptides, on the human malarial parasite Plasmodium falciparum.
Fennell BJ; Carolan S; Pettit GR; Bell A
J Antimicrob Chemother; 2003 Apr; 51(4):833-41. PubMed ID: 12654761
[TBL] [Abstract][Full Text] [Related]
23. Rhizoxin resistant mutants with an altered beta-tubulin gene in Aspergillus nidulans.
Takahashi M; Kobayashi H; Iwasaki S
Mol Gen Genet; 1989 Dec; 220(1):53-9. PubMed ID: 2691873
[TBL] [Abstract][Full Text] [Related]
24. Estramustine depolymerizes microtubules by binding to tubulin.
Dahllöf B; Billström A; Cabral F; Hartley-Asp B
Cancer Res; 1993 Oct; 53(19):4573-81. PubMed ID: 8402630
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin.
Hamel E
Cell Biochem Biophys; 2003; 38(1):1-22. PubMed ID: 12663938
[TBL] [Abstract][Full Text] [Related]
26. Tumor cells resistant to a microtubule-depolymerizing hemiasterlin analogue, HTI-286, have mutations in alpha- or beta-tubulin and increased microtubule stability.
Poruchynsky MS; Kim JH; Nogales E; Annable T; Loganzo F; Greenberger LM; Sackett DL; Fojo T
Biochemistry; 2004 Nov; 43(44):13944-54. PubMed ID: 15518543
[TBL] [Abstract][Full Text] [Related]
27. Cross-resistance of nocodazole-resistant mutants of CHO cells toward other microtubule inhibitors: similar mode of action of benzimidazole carbamate derivatives and NSC 181928 and TN-16.
Gupta RS
Mol Pharmacol; 1986 Aug; 30(2):142-8. PubMed ID: 3736539
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of vinca alkaloids and phomopsin hybrids.
Ngo QA; Roussi F; Cormier A; Thoret S; Knossow M; Guénard D; Guéritte F
J Med Chem; 2009 Jan; 52(1):134-42. PubMed ID: 19072542
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and evaluation of alpha-hydroxymethylated conjugated nitroalkenes for their anticancer activity: inhibition of cell proliferation by targeting microtubules.
Mohan R; Rastogi N; Namboothiri IN; Mobin SM; Panda D
Bioorg Med Chem; 2006 Dec; 14(23):8073-85. PubMed ID: 16891118
[TBL] [Abstract][Full Text] [Related]
30. Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin.
Madiraju C; Edler MC; Hamel E; Raccor BS; Balachandran R; Zhu G; Giuliano KA; Vogt A; Shin Y; Fournier JH; Fukui Y; Brückner AM; Curran DP; Day BW
Biochemistry; 2005 Nov; 44(45):15053-63. PubMed ID: 16274252
[TBL] [Abstract][Full Text] [Related]
31. Intra-allelic suppression of a mutation that stabilizes microtubules and confers resistance to colcemid.
Wang Y; Veeraraghavan S; Cabral F
Biochemistry; 2004 Jul; 43(28):8965-73. PubMed ID: 15248754
[TBL] [Abstract][Full Text] [Related]
32. Interaction of estramustine with tubulin isotypes.
Laing N; Dahllöf B; Hartley-Asp B; Ranganathan S; Tew KD
Biochemistry; 1997 Jan; 36(4):871-8. PubMed ID: 9020786
[TBL] [Abstract][Full Text] [Related]
33. Fluorescence spectroscopic methods to analyze drug-tubulin interactions.
Bhattacharyya B; Kapoor S; Panda D
Methods Cell Biol; 2010; 95():301-29. PubMed ID: 20466142
[TBL] [Abstract][Full Text] [Related]
34. Microtubule alterations and resistance to tubulin-binding agents (review).
Drukman S; Kavallaris M
Int J Oncol; 2002 Sep; 21(3):621-8. PubMed ID: 12168109
[TBL] [Abstract][Full Text] [Related]
35. Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation.
Xiao D; Pinto JT; Soh JW; Deguchi A; Gundersen GG; Palazzo AF; Yoon JT; Shirin H; Weinstein IB
Cancer Res; 2003 Oct; 63(20):6825-37. PubMed ID: 14583480
[TBL] [Abstract][Full Text] [Related]
36. beta-Tubulin mutation suppresses microtubule dynamics in vitro and slows mitosis in vivo.
Sage CR; Davis AS; Dougherty CA; Sullivan K; Farrell KW
Cell Motil Cytoskeleton; 1995; 30(4):285-300. PubMed ID: 7796459
[TBL] [Abstract][Full Text] [Related]
37. A radioligand binding assay for antitubulin activity in tumor cells.
Young DH; Rubio FM; Danis PO
J Biomol Screen; 2006 Feb; 11(1):82-9. PubMed ID: 16314405
[TBL] [Abstract][Full Text] [Related]
38. Interactions of antimitotic peptides and depsipeptides with tubulin.
Hamel E
Biopolymers; 2002; 66(3):142-60. PubMed ID: 12385035
[TBL] [Abstract][Full Text] [Related]
39. Exchangeable GTP binding site of the beta-subunit of brain tubulin in Alzheimer disease.
Khatoon S; Iqbal K
Prog Clin Biol Res; 1989; 317():801-7. PubMed ID: 2690125
[TBL] [Abstract][Full Text] [Related]
40. Molecular basis for determining the sensitivity of eucaryotes to the antimitotic drug rhizoxin.
Takahashi M; Matsumoto S; Iwasaki S; Yahara I
Mol Gen Genet; 1990 Jul; 222(2-3):169-75. PubMed ID: 2274023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
